BCLI: Phase 3 ALS Results Published in Muscle and Nerve…
By David Bautz, PhD
NASDAQ:BCLI
READ THE FULL BCLI RESEARCH REPORT
BrainStorm Cell ALS Candidate Shows Benefit In Patients With Less Severe Disease
BrainStorm Cell Therapeutics Inc (NASDAQ:BCLI) has announced the presentation of new analyses from the Phase 3 trial of NurOwn at the…
BrainStorm to Present ALS Phase 3 Biomarker Analyses at Annual NEALS Meeting October 6th, 2021
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that a scientific abstract titled "CSF biomarker correlations with primary
BrainStorm Cell Therapeutics To Present Phase 2 Data Results At Congress of the European Committee for Treatment and Research in Multiple Sclerosis Oct. 14 At 10:45 a.m. EDT
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that a scientific abstract titled "Phase 2 Safety and Efficacy Study
TENX: Second Quarter Results
By John Vandermosten, CFA
NASDAQ:TENX
READ THE FULL TENX RESEARCH REPORT
Brainstorm Cell Q2 EPS $(0.17) Beats $(0.20) Estimate
Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 32 percent increase over losses of $(0.25) per share from the
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Brainstorm Cell Therapeutics Announces Grant Of Multiple Patents For NurOwn
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the grant and/or allowance of a series of patents and patent
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)